The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) increased by $3.58 on Friday to finish at $541.59, up 0.67 percent. The last five days have seen an average of 1,141,920 shares of common stock traded. 9 times new highs were reached in the current year, with a fall of -$9.10. The average number of shares traded over the last 20 days was 1,152,505, while the average volume over the last 50 days totaled 1,527,522.
TMO stock dropped -3.29% since last month. On 08/22/23, the company’s shares reached a one-month low of $526.35. The stock touched a high of $609.85 on 01/24/23, after rallying from a low of $475.77 in 52 weeks. The price of TMO stock has declined by -1.65% or -$9.10 this year, reaching a new high 9 times. Still, the stock price is down -11.19% from the 52-week high.
Insider Transactions
TMO stock investors should be aware that Thermo Fisher Scientific Inc. (TMO) stock had its last reported insider trading activity 20 days ago on Aug 08. On Aug 08, Chairman & CEO CASPER MARC N sold 1,600 shares at $550.60 each. This transaction resulted in the insider making $880,960. On Aug 07, CASPER MARC N sold 10,000 shares at a price of US$551.94. After the transaction, the insider now owns 135,330 shares. Chairman & CEO CASPER MARC N had earlier sold 10,000 shares on Aug 04 for $550.33 a share. The transaction was completed for $5,503,317.
Valuation Metrics
Thermo Fisher Scientific Inc. (TMO) has a trailing price-to-earnings (P/E) ratio of 37.01. Beta for the stock is 0.77. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 4.77, the price-to-book (PB) ratio of 4.78, and the price-to-cash flow ratio of 35.47.
Company paid $0.35 per share in dividends, remained unchanged from $0.35 last year.
Financial Health
For the three months ended June 29, Thermo Fisher Scientific Inc.’s quick ratio was 1.00, while its current ratio was 1.40, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.67, and the total debt to equity ratio is 0.78. As far as profitability goes, gross margin for the trailing twelve months is 39.70% percent. Thermo Fisher Scientific Inc.’s EBITDA margin for the year ended June 29 was 26.51%, whereas its operating margin stood at 15.40% for the same period. Based on annual data, it had gross profit of $18.97 billion and revenue of $44.91 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. TMO’s return on assets (ROA) during the last 12 months has been 6.10%. There was a 9.80% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 13.20%.
Earnings Surprise
According to Thermo Fisher Scientific Inc.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $10.69 billion, while revenues fell by -2.65% to $10.71 billion. It was predicted that Thermo Fisher Scientific Inc.’s quarterly earnings would be $5.15, but it ended up being $5.42, beating the consensus by -5.00%. EBITDA was $2.43 billion for the quarter. At the end of Thermo Fisher Scientific Inc.’s most recent quarter ended June 29, its liabilities totaled 50.3 billion, while its total debt was $34.02 billion. Equity owned by shareholders amounts to $385.95 million.
Technical Picture
Here’s a quick look at Thermo Fisher Scientific Inc.’s (TMO) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 51.79%, suggesting the stock is Neutral, with a 23.20% historical volatility rate.
The stochastic %K and %D were 49.96% and 37.18% respectively, while the average true range (ATR) was 10.19. Based on the 14-day stochastic reading of 49.89%, the RSI (14) reading is 51.00%. On the 9-day MACD Oscillator, the stock is at 6.53, and the 14-day reading is at 2.29.
Analyst Ratings
In a note to investors, Robert W. Baird maintained its an Outperform rating on Thermo Fisher Scientific Inc. (NYSE: TMO). However, the firm raised their price target to $664, indicating a possible increase of 19.17% in the stock price. Analysts have assigned Thermo Fisher Scientific Inc. (TMO) an Overweight rating. TMO is a stock that is recommended for selling by 1 brokerage firm, while 5 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 3 rates it overweight and 17 others recommend it as a buy.
What is TMO’s price target for the next 12 months?
The current consensus forecast for the stock is between $520.00 and $698.00, with a median target price of $630.00. In analyzing these forecasts, the average price target given by analysts for Thermo Fisher Scientific Inc. (TMO) is $626.81.
